Philip L. Cyr
- Pharmacology
- Oncology
- Public Health, Environmental and Occupational Health
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine
- Co-authors
- Randall S. StaffordNatalia OlchanskiThomas F. GossLindsay BockstedtRobert H. HowlandNaomi SacksI. JensenSean D. Pokorney
- Topics
- Atrial Fibrillation Management and Outcomes (5 papers)Antiplatelet Therapy and Cardiovascular Diseases (5 papers)Cardiac Arrhythmias and Treatments (5 papers)
- Journals
- CirculationSHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Philip L. Cyr
31 papers receiving 348 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 84
- Oncology 64
- Public Health, Environmental and Occupational Health 62
- Cardiology and Cardiovascular Medicine 61
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Philip L. Cyr
This map shows the geographic impact of Philip L. Cyr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Cyr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Cyr more than expected).
Fields of papers citing papers by Philip L. Cyr
This network shows the impact of papers produced by Philip L. Cyr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Cyr. The network helps show where Philip L. Cyr may publish in the future.
Co-authorship network of co-authors of Philip L. Cyr
This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Cyr. A scholar is included among the top collaborators of Philip L. Cyr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Cyr. Philip L. Cyr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 11 | |
| 11 | Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes. | 7 |
| 12 | 5 | |
| 13 | 1 | |
| 14 | Abstract 15099: The Economic Burden of Insulin Resistance, Obesity, and Cardiovascular Disease in Medicare Beneficiaries 65 Years of Age and Older | 1 |
| 15 | 0 | |
| 16 | 16 | |
| 17 | 1 | |
| 18 | 3 | |
| 19 | 0 | |
| 20 | 79 |
About Philip L. Cyr
Philip L. Cyr is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine, having authored 37 papers that have together received 361 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Cardiac Arrhythmias and Treatments (5 papers). The work is most often cited by research in Geriatrics and Gerontology (45 citations), Biological Psychiatry (24 citations) and Applied Microbiology and Biotechnology (13 citations). Philip L. Cyr has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Randall S. Stafford, Natalia Olchanski, Thomas F. Goss, Lindsay Bockstedt, Robert H. Howland, Naomi Sacks, I. Jensen, Sean D. Pokorney, Weihong Fan and Thomas P. Lodise. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.